TCI Wealth Advisors’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

TCI Wealth Advisors’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$189	–	2406
2023 Q1	$189	Sell	5 -10	-67%	-$328	﹤0.01%	2344
2022 Q4	$447	Hold	15	–	–	﹤0.01%	2229
2022 Q3	$1K	Hold	15	–	–	﹤0.01%	2202
2022 Q2	$1K	Hold	15	–	–	﹤0.01%	2227
2022 Q1	$1K	Hold	15	–	–	﹤0.01%	2177
2021 Q4	$1K	Buy	15 +5	+50%	+$319	﹤0.01%	2265
2021 Q3	$1K	Hold	10	–	–	﹤0.01%	2334
2021 Q2	$1K	Sell	10 -10	-50%	-$1.38K	﹤0.01%	2273
2021 Q1	$3K	Sell	20 -5	-20%	-$963	﹤0.01%	1619
2020 Q4	$6K	Hold	25	–	–	﹤0.01%	835
2020 Q3	$3K	Buy	+25	New	+$1.34K	﹤0.01%	1044

Other funds holding TCON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's TCON Position: Q2 2023 in Review

TCI Wealth Advisors sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2023, closing a stake of 5 shares — an estimated $189 sold.

TCI Wealth Advisors first reported a position in TCON in Q3 2020 and held it in 11 quarters. The position peaked at $6K in Q4 2020. 27 funds tracked by Wall St. Rank hold TCON as of Q2 2023.

TCI Wealth Advisors reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 5 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $189.
TCI Wealth Advisors first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 11 quarters.
TCI Wealth Advisors's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $6K in Q4 2020.
27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.